Rosenblum Mark J (CIK 1329154) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy DCOY (9,682 shares), Buy SLRX (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Decoy Therapeutics Inc. (DCOY) | Chief Financial Officer | Buy | 9,682 | $0 |
| 2025-11-20 | Salarius Pharmaceuticals, Inc. (SLRX) | Exec VP Finance, CFO | Buy | 20,000 | $16,000 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02